Rahway-headquartered Merck announced Feb. 23 it is restructuring its Human Health division. The move aims to strengthen commercial execution and support a growing, diversified pipeline. The company ...
Hosted on MSN
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
Merck reported first-quarter results that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products. The pharmaceutical giant also narrowed its 2026 sales ...
Merck (MRK) faces a December 2028 patent expiration for Keytruda. The drug generates roughly half of total revenue. Merck split Human Health into two divisions to move faster on pricing and medical ...
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo Feb 27 (Reuters) - Merck will lay off about 150 ...
Merck (MRK) was up around 5% premarket on Thursday after it beat top- and bottom-line estimates for Q1 and issued a narrowed outlook for 2026. The Rahway, New Jersey–based company adjusted its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results